NewGenIvf (NIVF) Gross Profit (2024 - 2025)

NewGenIvf (NIVF) posted quarterly Gross Profit of $524025.0 for Q4 2025, down 2.8% year-over-year from $539135.0 in Q4 2024, and up 344.03% quarter-over-quarter from $118017.0 in Q3 2025.

NewGenIvf (NIVF) Gross Profit (2024 - 2025) Analysis & Trends

NewGenIvf (NIVF) has reported Gross Profit for 2 consecutive years, with $524025.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Gross Profit fell 2.8% year-over-year to $524025.0; the TTM figure through Dec 2025 stood at $1.8 million (changed N/A YoY), while the FY2025 annual figure was $955846.0, down 47.68% from the prior year.
  • Gross Profit rose to $524025.0 in Q4 2025 per NIVF's latest filing, from $118017.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $649077.0 in Q3 2024 and bottomed at $118017.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 88.19 Bn 90.61 Bn 15.19 Bn
2 Tenet Healthcare 21.59 Bn 21.56 Bn 4.45 Bn
3 Encompass Health 12.19 Bn 12.86 Bn 1.34 Bn
4 Davita 11.52 Bn 12.39 Bn 1.16 Bn
5 Ensign 10.59 Bn 10.27 Bn 306.24 Mn
6 Universal Health Services 8.79 Bn 8.72 Bn 3.29 Bn
7 Pacs 7.04 Bn 6.88 Bn 338.46 Mn
8 Chemed 6.96 Bn 6.92 Bn 221.47 Mn
9 Concentra Group Holdings Parent 4.52 Bn 4.38 Bn 192.10 Mn
10 NewGenIvf 9,048.24 -1.43 Mn 524,025.00

Historic Data

Download Data
DateValue
Dec 31, 2025 524,025.00
Dec 31, 2025 524,025.00
Sep 30, 2025 118,017.00
Sep 30, 2025 118,017.00
Dec 31, 2024 539,135.00
Dec 31, 2024 539,135.00
Sep 30, 2024 649,077.00
Sep 30, 2024 649,077.00